Stevenage Bioscience Catalyst is a joint venture between the Department for Business Innovation and Skills, GlaxoSmithKline, Wellcome and Innovate UK.
Our aim is to give the next generation of pharma and biotech companies access to a spectrum of translational research and development activities and opportunities.
This culture of open innovation will accelerate the discovery of cutting-edge healthcare solutions and place the UK bioscience sector at the forefront of worldwide biomedical innovation.
Stevenage Bioscience Catalyst offers access to equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies.
Our campus has been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs in the Incubator and scientists on the GSK R&D site, while respecting their freedom to interact with any commercial or academic partners.